These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17337006)

  • 1. Frontal dopaminergic abnormality in Tourette syndrome: a postmortem analysis.
    Yoon DY; Gause CD; Leckman JF; Singer HS
    J Neurol Sci; 2007 Apr; 255(1-2):50-6. PubMed ID: 17337006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased prefrontal D2 protein in Tourette syndrome: a postmortem analysis of frontal cortex and striatum.
    Minzer K; Lee O; Hong JJ; Singer HS
    J Neurol Sci; 2004 Apr; 219(1-2):55-61. PubMed ID: 15050438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal expression of dopamine and serotonin transporters associated with the pathophysiologic mechanism of Tourette syndrome.
    Jijun L; Zaiwang L; Anyuan L; Shuzhen W; Fanghua Q; Lin Z; Hong L
    Neurol India; 2010; 58(4):523-9. PubMed ID: 20739786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical localization of dopamine receptor subtypes (D1R-D5R) in Alzheimer's disease brain.
    Kumar U; Patel SC
    Brain Res; 2007 Feb; 1131(1):187-96. PubMed ID: 17182012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating dopamine transporter activity with 99mTc-TRODAT-1 SPECT in drug-naive Tourette's adults.
    Yeh CB; Lee CH; Chou YH; Chang CJ; Ma KH; Huang WS
    Nucl Med Commun; 2006 Oct; 27(10):779-84. PubMed ID: 16969259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extrastriatal dopaminergic dysfunction in tourette syndrome.
    Steeves TD; Ko JH; Kideckel DM; Rusjan P; Houle S; Sandor P; Lang AE; Strafella AP
    Ann Neurol; 2010 Feb; 67(2):170-81. PubMed ID: 20225192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive impairment in aged rhesus monkeys associated with monoamine receptors in the prefrontal cortex.
    Moore TL; Schettler SP; Killiany RJ; Herndon JG; Luebke JI; Moss MB; Rosene DL
    Behav Brain Res; 2005 May; 160(2):208-21. PubMed ID: 15863218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gilles de la Tourette syndrome is associated with hypermethylation of the dopamine D2 receptor gene.
    Müller-Vahl KR; Loeber G; Kotsiari A; Müller-Engling L; Frieling H
    J Psychiatr Res; 2017 Mar; 86():1-8. PubMed ID: 27883923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurobiological basis of serotonin-dopamine antagonists in the treatment of Gilles de la Tourette syndrome.
    Steeves TD; Fox SH
    Prog Brain Res; 2008; 172():495-513. PubMed ID: 18772048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postnatal alterations in dopaminergic markers in the human prefrontal cortex.
    Weickert CS; Webster MJ; Gondipalli P; Rothmond D; Fatula RJ; Herman MM; Kleinman JE; Akil M
    Neuroscience; 2007 Feb; 144(3):1109-19. PubMed ID: 17123740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic receptor D5 mRNA expression is increased in circulating lymphocytes of Tourette syndrome patients.
    Ferrari M; Termine C; Franciotta D; Castiglioni E; Pagani A; Lanzi G; Marino F; Lecchini S; Cosentino M; Balottin U
    J Psychiatr Res; 2008 Nov; 43(1):24-9. PubMed ID: 18329046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tourette's syndrome: a neurochemical analysis of postmortem cortical brain tissue.
    Singer HS; Hahn IH; Krowiak E; Nelson E; Moran T
    Ann Neurol; 1990 Apr; 27(4):443-6. PubMed ID: 1972320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine transporter binding in depressed patients with anhedonia.
    Sarchiapone M; Carli V; Camardese G; Cuomo C; Di Giuda D; Calcagni ML; Focacci C; De Risio S
    Psychiatry Res; 2006 Oct; 147(2-3):243-8. PubMed ID: 16952448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D2-like dopamine receptor density in Tourette syndrome measured by PET.
    Wong DF; Singer HS; Brandt J; Shaya E; Chen C; Brown J; Kimball AW; Gjedde A; Dannals RF; Ravert HT; Wilson PD; Wagner HN
    J Nucl Med; 1997 Aug; 38(8):1243-7. PubMed ID: 9255158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regionally selective changes in neurotransmitter receptors in the brain of the 5-HT1B knockout mouse.
    Ase AR; Reader TA; Hen R; Descarries L
    J Chem Neuroanat; 2008 Jul; 35(4):356-63. PubMed ID: 18406571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered mesolimbocortical and thalamic dopamine in Tourette syndrome.
    Gilbert DL; Christian BT; Gelfand MJ; Shi B; Mantil J; Sallee FR
    Neurology; 2006 Nov; 67(9):1695-7. PubMed ID: 17101911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in vivo neurochemistry study with PET.
    Wong DF; Brasić JR; Singer HS; Schretlen DJ; Kuwabara H; Zhou Y; Nandi A; Maris MA; Alexander M; Ye W; Rousset O; Kumar A; Szabo Z; Gjedde A; Grace AA
    Neuropsychopharmacology; 2008 May; 33(6):1239-51. PubMed ID: 17987065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor.
    Lee FJ; Pei L; Moszczynska A; Vukusic B; Fletcher PJ; Liu F
    EMBO J; 2007 Apr; 26(8):2127-36. PubMed ID: 17380124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-synuclein aggregation and cell death triggered by energy deprivation and dopamine overload are counteracted by D2/D3 receptor activation.
    Bellucci A; Collo G; Sarnico I; Battistin L; Missale C; Spano P
    J Neurochem; 2008 Jul; 106(2):560-77. PubMed ID: 18410503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-HT(1A) receptors in the frontal cortical brain areas in Cloninger type 1 and 2 alcoholics measured by whole-hemisphere autoradiography.
    Storvik M; Häkkinen M; Tupala E; Tiihonen J
    Alcohol Alcohol; 2009; 44(1):2-7. PubMed ID: 19029097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.